The nation of Zimbabwe has rejected a substantial American health deal worth $367m (£272m) over five years over the United States' insistence on confidential biological samples.
This rejection came to light following a official document dated December was disclosed, which showed Head of State Emmerson Mnangagwa deemed the agreement was "unbalanced".
An official spokesman has since stated that the United States was requesting genetic material for scientific study and profit while was not willing to share the resulting advantages from any future medical innovations.
"We will now turn to the challenging and unfortunate process of ending our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had donated more than $1.9bn as health assistance to Zimbabwe during the past two decades.
A medical body in Zimbabwe has called for continued talks to find a agreement agreeable to both sides so the nation's critical HIV programme can be sustained.
Broader Background
This rejection comes after a comparable case in Kenya, where a court blocked a similar health funding agreement following legal challenges were raised about the safety of citizens' medical information.
After resuming the presidency recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
USAID had administered assistance for the American government, but Trump stated its spending was "wasteful" and his government was pursuing government-to-government deals to enhance transparency and responsibility.
As per reports, Sixteen nations in Africa have to date agreed to similar agreements, constituting more than $18.3bn in committed funds.
Details of the Declined Deal
The money for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this cooperation might have yielded immense advantages for Zimbabwean communities, particularly the 1.2 million presently receiving HIV treatment via American-funded initiatives," the Ambassador said.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"Zimbabwe was being asked to share its biological resources and data indefinitely, with no corresponding promise of access to any medical innovations – like vaccines, diagnostics, or treatments – that might result from that shared data," his statement read.
"Put simply, our nation would supply the raw materials for medical research without any assurance that the final treatments would be accessible to our people if a future disease outbreak emerge."
National Interest and International Frameworks
He also noted that the US's withdrawal from the global health body and its push of bilateral deals were undermining structures previously set up via the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system designed to deal with future pandemics.
"This framework is intended to ensure that when a nation contributes its information, the benefits – including vaccines and treatments – are shared equitably, not monopolised solely by those with the capability to create them."
Zimbabwe's reservations regarding the US deal "are not meant as opposition to America," he added.
"We are open to ongoing dialogue with our American counterparts on how subsequent co-operation might be structured in a way that respects the sovereignty and interests of both nations."
Health Experts Reaction
Medical experts said it recognised the government's concerns, but suggested that negotiations need to persist considering much of the nation's Aids initiatives relied on foreign aid.
"If specific concerns exist, such as those involving data governance or agreement terms, these can frequently be resolved via technical clarification and mutually agreed protections," it added.
The situation highlights the ongoing challenges between receiving vital international aid and safeguarding local interests in an increasingly data-driven world.